DocuSign
E-signatures & contract management
- Legal & Compliance Tools
- Subscription
For · Legal, HR and sales teams in organisations that regularly handle contracts
DocuSign is the market leader in e-signatures and Contract Lifecycle Management (CLM). The tool is widely used in legal, HR, and sales processes. DocuSign operates with envelope-based pricing: you pay per document sent for signature. For high volumes, enterprise plans with a fixed fee are more cost-effective.
A common issue is that organisations purchase envelope packages based on peak volumes, while the average usage is much lower. This leads to structural over-purchasing.
Purchasing Considerations
- Analyse your actual envelope usage
DocuSign provides detailed usage reports. Analyse average and peak usage over the past 12 months before choosing a package. Most organisations purchase 30-50% more envelopes than they actually use.
- Compare Business Pro vs. Enterprise
Business Pro offers advanced features for most use cases. Enterprise adds compliance tools and SSO. For many organisations, Business Pro is sufficient and considerably cheaper.
Compliance Risks
- eIDAS compliance for EU contracts
Legally binding contracts in the EU must meet specific requirements under the eIDAS regulation. Not all DocuSign plans include a qualified electronic signature (QES) by default. Check if your plan complies.
Frequently Asked Questions about DocuSign
Frequently asked questions about DocuSign licenses and purchasing.
What is an envelope in DocuSign?
An envelope is a shipment of one or multiple documents for signing to one or more recipients. You pay per envelope, not per document or signature.
Does DocuSign comply with GDPR?
DocuSign offers a GDPR-compliant configuration, but this requires actively enabling EU data storage and additional contractual agreements through a Data Processing Agreement (DPA).
Relevant knowledge base articles
Sharper purchasing with DocuSign?
SoftVaro negotiates the best deal for you with DocuSign. Independent, transparent and within 24 hours.